Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3018845rdf:typepubmed:Citationlld:pubmed
pubmed-article:3018845lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0085140lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0040162lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0024334lld:lifeskim
pubmed-article:3018845lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:3018845pubmed:issue4lld:pubmed
pubmed-article:3018845pubmed:dateCreated1986-10-6lld:pubmed
pubmed-article:3018845pubmed:abstractTextBinding of [3H]thyrotropin-releasing hormone (TRH) to its receptors in the rat limbic forebrain was partially displaced by 5-hydroxytryptamine (5-HT, ligand for 5-HT1 receptors) and (+)-lysergic acid diethylamide ((+)-LSD, ligand for 5-HT1 and 5-HT2 receptors) at nanomolar concentrations. Spiperone (ligand for 5-HT2 receptors) displaced [3H]TRH in a dose-dependent manner at micromolar concentrations. These results suggest that some TRH receptors are related to 5-HT1 receptors, probably adjoining them on the membrane. This type of TRH receptor is shown to be among the high-affinity receptors which we reported previously. The significance of the receptor-coexistence is such that TRH facilitates serotonergic transmission by increasing the density of 5-HT1 receptors. This finding seems to support a pharmacological observation of other investigators that TRH potentiates 5-HT-induced hyperactivity in mice, probably by affecting postsynaptic 5-HT receptors.lld:pubmed
pubmed-article:3018845pubmed:languageenglld:pubmed
pubmed-article:3018845pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:citationSubsetIMlld:pubmed
pubmed-article:3018845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3018845pubmed:statusMEDLINElld:pubmed
pubmed-article:3018845pubmed:monthJullld:pubmed
pubmed-article:3018845pubmed:issn0167-0115lld:pubmed
pubmed-article:3018845pubmed:authorpubmed-author:InanagaKKlld:pubmed
pubmed-article:3018845pubmed:authorpubmed-author:TeshimaSSlld:pubmed
pubmed-article:3018845pubmed:authorpubmed-author:SatohHHlld:pubmed
pubmed-article:3018845pubmed:authorpubmed-author:FunatsuKKlld:pubmed
pubmed-article:3018845pubmed:issnTypePrintlld:pubmed
pubmed-article:3018845pubmed:volume14lld:pubmed
pubmed-article:3018845pubmed:ownerNLMlld:pubmed
pubmed-article:3018845pubmed:authorsCompleteYlld:pubmed
pubmed-article:3018845pubmed:pagination293-9lld:pubmed
pubmed-article:3018845pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:meshHeadingpubmed-meshheading:3018845-...lld:pubmed
pubmed-article:3018845pubmed:year1986lld:pubmed
pubmed-article:3018845pubmed:articleTitle5-Hydroxytryptamine and (+)-lysergic acid diethylamide displace [3H]thyrotropin-releasing hormone at its binding sites in the rat limbic forebrain.lld:pubmed
pubmed-article:3018845pubmed:publicationTypeJournal Articlelld:pubmed